Article metrics
Other content recommended for you
- Advances in the diagnosis and management of IgG4 related disease
- IgG4-related disease: a rare but treatable cause of refractory intracranial hypertension
- Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
- IgG4-related hypertrophic pachymeningitis with chronic subdural haematoma
- Intracranial spread of IgG4-related disease via skull base foramina
- A case of multiple cranial nerve palsies
- Ocular adnexal IgG4-related disease: CT and MRI findings
- Rituximab for IgG4-related disease: a prospective, open-label trial
- Immunoglobulin G4-related intracranial inflammatory pseudotumours along both the oculomotor nerves
- The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease